sebetrelstat – Patient Worthy

Photo courtesy of Towfiqu Barbhuiya on Unsplash

Positive Phase 1 Data Available on Sebetralstat for HAE

Post author:Jessica Lynn
Post published:November 30, 2022
Post category:Hereditary Angiodema Hereditary angioedema

According to a late October 2022 news release from pharmaceutical company KalVista Pharmaceuticals, Inc. (“KalVista”), the company released positive data from a Phase 1 study evaluating oral sebetralstat for…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More